Human Granulocytic Ehrlichiosis in Belgium: An underestimated cause of disease

Journal of Infection

Volumn 47, Issue 2, 2003, Pages 129-132

  Heyman, Paul ^a   Cochez, C ^a   Bigaignon, G ^b   Guillaume, B ^b   Zizi, M ^a   Vandenvelde, C ^a  

^a QUEEN ASTRID MILITARY HOSPITAL   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

HGE; Human Granulocytic Ehrlichiosis; Lyme; Serology

Indexed keywords

DOXYCYCLINE;

ADOLESCENT; ADULT; AGED; ANAMNESIS; ANAPLASMA; ARTICLE; BELGIUM; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CARRIER; EHRLICHIOSIS; EUROPE; FEMALE; HUMAN; IMMUNOFLUORESCENCE; IXODES; LYME DISEASE; MALE; NONHUMAN; PARASITE SERODIAGNOSIS; SCHOOL CHILD; SCREENING TEST; TICK BITE; TICK BORNE DISEASE; WESTERN BLOTTING; ZOONOSIS;

EID: 0041311115     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-4453(03)00056-2     Document Type: Article

References (14)

1. Bakken JS, Dumler JS. Human granulocytic ehrlichiosis. Clin Infect Dis 2000;31(2):554-560.
2. Chen SM, Dumler JS, Bakken JS, Walker DH. Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease. J Clin Microbiol 1994;32(3):589-595.
3. Chen SM, Dumler JS, Feng HM, Walker DH. Identification of the antigenic constituents of Ehrlichia chaffeensis. Am J Trop Med Hyg 1994; 50(1):52-58.
4. Pierard D, Levtchenko E, Dawson JE, Lauwers S. Ehrlichiosis in Belgium. Lancet 1995;346(8984):1233-1234.
5. Guillaume B, Heyman P, Lafontaine S, Vandenvelde C, Delmee M, Bigaignon G. Seroprevalence of human granulocytic ehrlichiosis infection in Belgium. Eur J Clin Microbiol Infect Dis 2002;21(5):397-400.
6. Bjoersdorff A, Wittesjo B, Berglun J, Massung RF, Eliasson I. Human granulocytic ehrlichiosis as a common cause of tick-associated fever in Southeast Sweden: report from a prospective clinical study. Scand J Infect Dis 2002;34(3): 187-191.
7. Belongia EA, Reed KD, Mitchell PD, et al. Clinical and epidemiological features of early Lyme disease and human granulocytic ehrlichiosis in Wisconsin. Clin Infect Dis 1999; 29(6):1472-1477.
8. Bakken JS, Haller I, Riddell D, Walls JJ, Dumler JS. The serological response of patients infected with the agent of human granulocytic ehrlichiosis. Clin Infect Dis 2002;34(1): 22-27.
9. Skarphedinsson S, Sogaard P, Pedersen C. Seroprevalence of human granulocytic ehrlichiosis in high-risk groups in Denmark. Scand J Infect Dis 2001;33(3):206-210.
10. Unver A, Felek S, Paddock CD, et al. Western blot analysis of sera reactive to human monocytic ehrlichiosis and human granulocytic ehrlichiosis agents. J Clin Microbiol 2001; 39(11):3982-3986.
11. Walls JJ, Caturegli P, Bakken JS, Asanovich KM, Dumler JS. Improved sensitivity of PCR for diagnosis of human granulocytic ehrlichiosis using epank 1 genes of Ehrlichia phagocytophila-group ehrlichiae. J Clin Microbiol 2000;38(1): 354-356.
12. Ramsey AH, Belongia EA, Gale CM, Davis JP. Outcomes of treated human granulocytic ehrlichiosis cases. Emerg Infect Dis 2002;8(4):398-401.
13. Dumler JS, Asanovich KM, Bakken JS, Richter P, Kimsey R, Madigan JE. Serologic cross-reactions among Ehrlichia equi, Ehrlichia phagocytophila, and human granulocytic Ehrlichia. J Clin Microbiol 1995;33(5):1098-1103.
14. Ducoffre G. Surveillance van Infectieuze Aandoeningen door een Netwerk van Laboratoria voor Microbiologie. Epidemiologische Trends 1983-1999. Scientific Institute of Public Health (IPH), Department of Epidemiology-Toxicology, Section Epidemiology. http://www.iph.fgov.be/epidemio, (2002).